93 related articles for article (PubMed ID: 20152583)
1. Targeting diuretic use for malignant ascites--two case reports highlighting the value of the serum-ascites albumin gradient in a palliative setting.
Husbands EL
J Pain Symptom Manage; 2010 Feb; 39(2):e7-9. PubMed ID: 20152583
[No Abstract] [Full Text] [Related]
2. Management of ascites. A review.
Watanabe A
J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic paracentesis. A two-step approach.
Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M
Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999
[TBL] [Abstract][Full Text] [Related]
4. [Supportive care for malignant ascites in palliative phase: Place of paracentesis and diuretics].
Gamblin V; Da Silva A; Villet S; El Hajbi F
Bull Cancer; 2015 Nov; 102(11):940-5. PubMed ID: 26477275
[TBL] [Abstract][Full Text] [Related]
5. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.
Dittrich S; Yordi LM; de Mattos AA
Hepatogastroenterology; 2001; 48(37):166-8. PubMed ID: 11268957
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma associated with hypercalcaemia and ascites presenting as sclerosing cholangitis.
D'Costa DF
Br J Clin Pract; 1994; 48(4):217-8. PubMed ID: 7917805
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approaches to the treatment of edema and ascites: the use of diuretics.
Somberg JC; Molnar J
Am J Ther; 2009; 16(1):98-101. PubMed ID: 19142158
[TBL] [Abstract][Full Text] [Related]
9. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
Inoue J; Mori Y; Kawamura T
Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
[No Abstract] [Full Text] [Related]
10. Management of symptomatic malignant ascites with diuretics: two case reports and a review of the literature.
Sharma S; Walsh D
J Pain Symptom Manage; 1995 Apr; 10(3):237-42. PubMed ID: 7629417
[TBL] [Abstract][Full Text] [Related]
11. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial.
Soderlund C; Linder S
Gastrointest Endosc; 2006 Jun; 63(7):986-95. PubMed ID: 16733114
[TBL] [Abstract][Full Text] [Related]
12. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt.
Schiano TD; Black M; Hills C; Ter H; Bellary S; Miller LS
South Med J; 2000 Mar; 93(3):305-9. PubMed ID: 10728519
[TBL] [Abstract][Full Text] [Related]
13. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Lowenthal DT; Shear L
Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
[No Abstract] [Full Text] [Related]
14. Palliation for nonpancreatic malignant obstruction of the biliary tract.
Finch MD; Butler JA
Surg Gynecol Obstet; 1990 May; 170(5):437-40. PubMed ID: 1691530
[TBL] [Abstract][Full Text] [Related]
15. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites.
Paré P; Talbot J; Hoefs JC
Gastroenterology; 1983 Aug; 85(2):240-4. PubMed ID: 6862152
[TBL] [Abstract][Full Text] [Related]
16. [Endoscopic and radiological interventional therapy of benign and malignant bile duct stenoses].
Hartmann D; Jakobs R; Schilling D; Riemann JF
Zentralbl Chir; 2003 Nov; 128(11):936-43. PubMed ID: 14669114
[TBL] [Abstract][Full Text] [Related]
17. Pattern and prognostic factors in patients with malignant ascites: a retrospective study.
Ayantunde AA; Parsons SL
Ann Oncol; 2007 May; 18(5):945-9. PubMed ID: 17298959
[TBL] [Abstract][Full Text] [Related]
18. Images of interest. Hepatobiliary and pancreatic: cholangiocarcinoma with chylous ascites.
Yamamoto N; Shiraki K; Yamanaka Y; Sugimoto K; Murata K; Nakano T
J Gastroenterol Hepatol; 2004 Dec; 19(12):1417. PubMed ID: 15610317
[No Abstract] [Full Text] [Related]
19. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
Cavatorta F; Queirolo C; Brignole M; Zangani F
Clin Ter; 1980 Jan; 92(2):143-53. PubMed ID: 7389274
[No Abstract] [Full Text] [Related]
20. The use of albumin in patients with decompensated cirrhosis: the case in favor.
Maor Y
Isr Med Assoc J; 2005 Feb; 7(2):115-8. PubMed ID: 15729966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
